Biography and Research Information
OverviewAI-generated summary
Claire Doshier's research investigates the molecular mechanisms underlying cancer, with a recent focus on identifying therapeutic targets in lymphoma. Her work has explored the role of NEK2 as a regulator of oncogenic pathways in lymphoma, as indicated by her 2023 publication "Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma." Doshier also has research interests in cellular senescence and regeneration, as demonstrated in her 2024 publication "Damage-Induced Senescent Immune Cells Regulate Regeneration of the Zebrafish Retina." Her scholarship metrics include an h-index of 3, 59 total publications, and 19 total citations.
Metrics
- h-index: 3
- Publications: 59
- Citations: 20
Selected Publications
-
Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma (2023)
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics